Moshit Lindzen

1.9k total citations
32 papers, 889 citations indexed

About

Moshit Lindzen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Moshit Lindzen has authored 32 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Moshit Lindzen's work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Moshit Lindzen is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Moshit Lindzen collaborates with scholars based in Israel, Italy and Germany. Moshit Lindzen's co-authors include Yosef Yarden, Haim Garty, Steven J.D. Karlish, Nadège Gaborit, Maria Füzesi, Sara Lavi, Yosef Yarden, Р. И. Айзман, Yael Lifshitz and Nir Ben‐Chetrit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Moshit Lindzen

32 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moshit Lindzen Israel 20 524 393 196 179 105 32 889
David M. Nanus United States 13 442 0.8× 350 0.9× 200 1.0× 135 0.8× 88 0.8× 27 902
Elizabeth Luis United States 15 497 0.9× 275 0.7× 93 0.5× 271 1.5× 107 1.0× 18 885
Hartwig Hennekes Germany 15 522 1.0× 232 0.6× 245 1.3× 307 1.7× 155 1.5× 25 1.3k
T Sethi United Kingdom 17 542 1.0× 422 1.1× 141 0.7× 44 0.2× 98 0.9× 37 1.1k
Fook-Thean Lee Australia 19 449 0.9× 341 0.9× 91 0.5× 400 2.2× 129 1.2× 29 991
K Horsch Switzerland 7 378 0.7× 385 1.0× 50 0.3× 97 0.5× 119 1.1× 7 684
Valérie Pawlowski France 12 404 0.8× 213 0.5× 56 0.3× 77 0.4× 47 0.4× 17 752
Emmanuel Chautard France 18 515 1.0× 274 0.7× 171 0.9× 73 0.4× 99 0.9× 39 900
Nir Ben‐Chetrit Israel 15 474 0.9× 353 0.9× 89 0.5× 74 0.4× 187 1.8× 15 896
Michael Ronellenfitsch Germany 22 661 1.3× 261 0.7× 217 1.1× 74 0.4× 81 0.8× 73 1.3k

Countries citing papers authored by Moshit Lindzen

Since Specialization
Citations

This map shows the geographic impact of Moshit Lindzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshit Lindzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshit Lindzen more than expected).

Fields of papers citing papers by Moshit Lindzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshit Lindzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshit Lindzen. The network helps show where Moshit Lindzen may publish in the future.

Co-authorship network of co-authors of Moshit Lindzen

This figure shows the co-authorship network connecting the top 25 collaborators of Moshit Lindzen. A scholar is included among the top collaborators of Moshit Lindzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshit Lindzen. Moshit Lindzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nevo, Shir, N Frenkeĺ, Noam Kadouri, et al.. (2024). Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response. Science Immunology. 9(91). eabq6930–eabq6930. 22 indexed citations
2.
Simoni‐Nieves, Arturo, Moshit Lindzen, Donatella Romaniello, et al.. (2024). A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib. Cell Reports Medicine. 5(9). 101703–101703. 9 indexed citations
3.
Noronha, Ashish, Moshit Lindzen, Emily K. Makowski, et al.. (2023). Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nature Biomedical Engineering. 8(1). 30–44. 19 indexed citations
4.
Pérez‐Martínez, Dayana, et al.. (2022). Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies. Frontiers in Oncology. 12. 951267–951267. 1 indexed citations
5.
Marrocco, Ilaria, Ashish Noronha, Mary Luz Uribe, et al.. (2021). Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors. Cancer Research. 81(14). 3862–3875. 6 indexed citations
6.
Marrocco, Ilaria, Donatella Romaniello, Diana Drago-García, et al.. (2021). Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO Molecular Medicine. 13(4). e13144–e13144. 18 indexed citations
7.
Romaniello, Donatella, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.. (2020). Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers. 12(9). 2394–2394. 40 indexed citations
8.
Romaniello, Donatella, Luigi Mazzeo, Maicol Mancini, et al.. (2018). A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clinical Cancer Research. 24(22). 5610–5621. 43 indexed citations
9.
Enuka, Yehoshua, Morris E. Feldman, Animesh Chowdhury, et al.. (2017). Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone. Nucleic Acids Research. 45(22). 12681–12699. 18 indexed citations
10.
Mancini, Maicol, Hilah Gal, Nadège Gaborit, et al.. (2017). An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors. EMBO Molecular Medicine. 10(2). 294–308. 42 indexed citations
11.
Savidor, Alon, Dalia Elinger, Yosef Yarden, et al.. (2017). Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination. Molecular & Cellular Proteomics. 16(6). 1151–1161. 20 indexed citations
12.
Gaborit, Nadège, Ali Abdul‐Hai, Maicol Mancini, et al.. (2015). Examination of HER3 targeting in cancer using monoclonal antibodies. Proceedings of the National Academy of Sciences. 112(3). 839–844. 35 indexed citations
13.
Carvalho, Sílvia, Moshit Lindzen, Mattia Lauriola, et al.. (2015). An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors. Oncogene. 35(4). 438–447. 38 indexed citations
14.
Lauriola, Mattia, Yehoshua Enuka, Amit Zeisel, et al.. (2014). Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. Nature Communications. 5(1). 5073–5073. 49 indexed citations
15.
Ferraro, Daniela A., Nadège Gaborit, Ruth Maron, et al.. (2013). Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR. Proceedings of the National Academy of Sciences. 110(5). 1815–1820. 93 indexed citations
16.
Lindzen, Moshit, Sílvia Carvalho, Alex Starr, et al.. (2011). A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis. Oncogene. 31(30). 3505–3515. 25 indexed citations
17.
Füzesi, Maria, Kay‐Eberhard Gottschalk, Moshit Lindzen, et al.. (2005). Covalent Cross-links between the γ Subunit (FXYD2) and α and β Subunits of Na,K-ATPase. Journal of Biological Chemistry. 280(18). 18291–18301. 29 indexed citations
18.
Garty, Haim, Moshit Lindzen, Maria Füzesi, et al.. (2003). A Specific Functional Interaction between CHIF and Na,K‐ATPase. Annals of the New York Academy of Sciences. 986(1). 395–400. 12 indexed citations
19.
Lindzen, Moshit, et al.. (2003). Structure-Function Relations of Interactions between Na,K-ATPase, the γ Subunit, and Corticosteroid Hormone-induced Factor. Journal of Biological Chemistry. 278(21). 18738–18743. 36 indexed citations
20.
Lindzen, Moshit, Р. И. Айзман, Yael Lifshitz, et al.. (2003). Domains Involved in the Interactions between FXYD and Na,K‐ATPase. Annals of the New York Academy of Sciences. 986(1). 530–531. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Nanus Breakdown of academic impact, for papers by Elizabeth Luis Breakdown of academic impact, for papers by Hartwig Hennekes Breakdown of academic impact, for papers by T Sethi Breakdown of academic impact, for papers by Fook-Thean Lee Breakdown of academic impact, for papers by K Horsch Breakdown of academic impact, for papers by Valérie Pawlowski Breakdown of academic impact, for papers by Emmanuel Chautard Breakdown of academic impact, for papers by Nir Ben‐Chetrit Breakdown of academic impact, for papers by Michael Ronellenfitsch
Rankless by CCL
2026